Literature DB >> 9129409

Dual-phase helical CT of the liver: value of an early-phase acquisition in the differential diagnosis of noncystic focal lesions.

L Van Hoe1, A L Baert, S Gryspeerdt, G Vandenbosh, F Nevens, W Van Steenbergen, G Marchal.   

Abstract

OBJECTIVE: Contrast-enhanced helical CT images of the liver are usually obtained during the portal vein phase (PVP), during which the parenchyma achieves peak enhancement. The purpose of this study was to determine whether the addition of arterial-phase (AP) scans would lead to improved characterization of focal lesions.
MATERIALS AND METHODS: We reviewed the CT appearance of 102 focal lesions with a proven diagnosis. In the first part of the study, we assessed whether the addition of AP scans influenced the diagnostic performance of the three observers. In the second part of the study, we analyzed the morphologic appearance revealed on CT scans of the different types of lesions in the AP and PVP.
RESULTS: The addition of AP scans led to a significant increase in the number of correct diagnoses: 71 lesions (70%) were correctly diagnosed with CT scans in both the AP and the PVP, compared with 54 lesions (53%) correctly diagnosed with CT scans in the PVP alone (p < .01). The largest difference was observed in the diagnosis of focal nodular hyperplasia (FNH) and adenoma (16/24 correct diagnoses instead of 6/24) (p < .005). Conversely, AP images did not significantly contribute to the diagnosis of hemangiomas and metastases. The following morphologic features were seen much more often on AP scans than on PVP scans and had a high positive predictive value (PPV): spoke-wheel pattern (FNH; PPV, 100%), central feeding vessel (FNH; PPV, 100%), and heterogeneous appearance with hyperdense components (hepatocellular carcinoma; PPV, 75%).
CONCLUSION: Our data show that the radiologists' evaluation of CT scans in both the AP and the PVP improves the differentiation of hepatocellular carcinoma and FNH from other types of hepatic neoplasms.

Entities:  

Mesh:

Year:  1997        PMID: 9129409     DOI: 10.2214/ajr.168.5.9129409

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

1.  Benign Neoplasms of the Liver.

Authors:  Michael K. Porayko; Cuckoo Choudhary
Journal:  Curr Treat Options Gastroenterol       Date:  2001-12

2.  Contrast-enhanced ultrasound features of histologically proven focal nodular hyperplasia: diagnostic performance compared with contrast-enhanced CT.

Authors:  Wei Wang; Li-Da Chen; Ming-De Lu; Guang-Jian Liu; Shun-Li Shen; Zuo-Feng Xu; Xiao-Yan Xie; Yan Wang; Lu-Yao Zhou
Journal:  Eur Radiol       Date:  2013-04-27       Impact factor: 5.315

3.  Radiomics Study for Differentiating Focal Hepatic Lesions Based on Unenhanced CT Images.

Authors:  Xitong Zhao; Pan Liang; Liuliang Yong; Yan Jia; Jianbo Gao
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

4.  Characterization of focal hepatic lesions with contrast-enhanced C-cube gray scale ultrasonography.

Authors:  Wen-Ping Wang; Hong Ding; Qing Qi; Feng Mao; Zhi-Zhang Xu; Masatoshi Kudo
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

5.  Liver cell adenoma and liver cell adenomatosis.

Authors:  Ludger Barthelmes; Iain S Tait
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

6.  Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions.

Authors:  Renate Hammerstingl; Alexander Huppertz; Josy Breuer; Thomas Balzer; Anthony Blakeborough; Rick Carter; Lluis Castells Fusté; Gertraud Heinz-Peer; Werner Judmaier; Michael Laniado; Riccardo M Manfredi; Didier G Mathieu; Dieter Müller; Koenraad Mortelè; Peter Reimer; Maximilian F Reiser; Philip J Robinson; Kohkan Shamsi; Michael Strotzer; Matthias Taupitz; Bernd Tombach; Gianluca Valeri; Bernhard E van Beers; Thomas J Vogl
Journal:  Eur Radiol       Date:  2007-12-06       Impact factor: 5.315

7.  Optimal dose and injection duration (injection rate) of contrast material for depiction of hypervascular hepatocellular carcinomas by multidetector CT.

Authors:  Yumi Yanaga; Kazuo Awai; Yoshiharu Nakayama; Takeshi Nakaura; Yoshitaka Tamura; Yoshinori Funama; Masahito Aoyama; Naoki Asada; Yasuyuki Yamashita
Journal:  Radiat Med       Date:  2007-07-27

8.  Contrast enhancement on 100- and 120 kVp hepatic CT scans at thin adults in a retrospective cohort study: Bayesian inference of the optimal enhancement probability.

Authors:  Takanori Masuda; Takeshi Nakaura; Yoshinori Funama; Tomoyasu Sato; Toru Higaki; Yoriaki Matsumoto; Yukari Yamashita; Naoyuki Imada; Masao Kiguchi; Yasutaka Baba; Yasuyuki Yamashita; Kazuo Awai
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

9.  Liver cancer imaging: role of CT, MRI, US and PET.

Authors:  Maria Raquel Oliva; Sanjay Saini
Journal:  Cancer Imaging       Date:  2004-04-02       Impact factor: 3.909

10.  Acoustic radiation force impulse elastography for focal hepatic tumors: usefulness for differentiating hemangiomas from malignant tumors.

Authors:  Ji Eun Kim; Jae Young Lee; Kyung Soo Bae; Joon Koo Han; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.